Form 8-K - Current report:
SEC Accession No. 0001493152-26-005840
Filing Date
2026-02-10
Accepted
2026-02-09 20:08:33
Documents
36
Period of Report
2026-02-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38168
2 EX-99.1 ex99-1.htm EX-99.1 23926
3 GRAPHIC ex99-1_001.jpg GRAPHIC 239659
4 GRAPHIC ex99-1_002.jpg GRAPHIC 485709
5 GRAPHIC ex99-1_003.jpg GRAPHIC 287279
6 GRAPHIC ex99-1_004.jpg GRAPHIC 308534
7 GRAPHIC ex99-1_005.jpg GRAPHIC 314862
8 GRAPHIC ex99-1_006.jpg GRAPHIC 295502
9 GRAPHIC ex99-1_007.jpg GRAPHIC 235627
10 GRAPHIC ex99-1_008.jpg GRAPHIC 296704
11 GRAPHIC ex99-1_009.jpg GRAPHIC 360499
12 GRAPHIC ex99-1_010.jpg GRAPHIC 285506
13 GRAPHIC ex99-1_011.jpg GRAPHIC 304813
14 GRAPHIC ex99-1_012.jpg GRAPHIC 258525
15 GRAPHIC ex99-1_013.jpg GRAPHIC 223550
16 GRAPHIC ex99-1_014.jpg GRAPHIC 268310
17 GRAPHIC ex99-1_015.jpg GRAPHIC 349974
18 GRAPHIC ex99-1_016.jpg GRAPHIC 276272
19 GRAPHIC ex99-1_017.jpg GRAPHIC 358302
20 GRAPHIC ex99-1_018.jpg GRAPHIC 301344
21 GRAPHIC ex99-1_019.jpg GRAPHIC 238390
22 GRAPHIC ex99-1_020.jpg GRAPHIC 281294
23 GRAPHIC ex99-1_021.jpg GRAPHIC 254789
24 GRAPHIC ex99-1_022.jpg GRAPHIC 316368
25 GRAPHIC ex99-1_023.jpg GRAPHIC 299066
  Complete submission text file 0001493152-26-005840.txt   9655032

Data Files

Seq Description Document Type Size
26 XBRL SCHEMA FILE cldi-20260206.xsd EX-101.SCH 3017
27 XBRL LABEL FILE cldi-20260206_lab.xml EX-101.LAB 34239
28 XBRL PRESENTATION FILE cldi-20260206_pre.xml EX-101.PRE 22360
38 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3390
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Filer) CIK: 0001855485 (see all company filings)

EIN.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40789 | Film No.: 26613080
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)